
Carlsmed Inc (CARL) Stock Forecast & Price Target
Carlsmed Inc (CARL) Analyst Ratings
Bulls say
Carlsmed is a rapidly growing medical technology company that is delivering personalized solutions for spine surgery through its FDA-cleared Aprevo technology platform. By providing customized pre-operative planning and implants, Carlsmed is able to improve clinical outcomes for patients undergoing spine fusion procedures. Additionally, the company has secured robust reimbursement from third-party payers, which sets it apart from traditional spine surgery. Carlsmed's focus on innovation and integration in the spine surgery market bodes well for its long-term growth potential.
Bears say
Carlsmed is a commercial-stage company operating in a highly competitive market with a concentrated customer base and facing reimbursement risks. While the company's entrance into the cervical spine market presents a significant opportunity, there are still uncertainties around utilization and adoption among existing customers, leading to a negative outlook on the stock.
This aggregate rating is based on analysts' research of Carlsmed Inc and is not a guaranteed prediction by Public.com or investment advice.
Carlsmed Inc (CARL) Analyst Forecast & Price Prediction
Start investing in Carlsmed Inc (CARL)
Order type
Buy in
Order amount
Est. shares
0 shares